Absract
We herein describe a new method to fine-map GWAS-identified risk loci based on the Bayesian Least Absolute Shrinkage Selection Operator (LASSO) combined with a Monte Carlo Markov Chain (MCMC) approach, and corresponding software package (BayesFM). We characterize the performances of BayesFM using simulated data, showing that it outperforms standard forward selection both in terms of sensitivity and specificity. We apply the method to the NOD2 locus, a well-established risk locus for Crohn’s disease, in which we identify 13 putative independent signals.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.